Results 151 to 160 of about 3,132 (216)

Real-world outcomes after switching to faricimab in previously treated neovascular age-related macular degeneration: longitudinal outcomes up to 24 months. [PDF]

Int J Retina Vitreous
Egger D, Amesbauer F, Mohamed H, Thiel KE, Angermann R, Waldstein SM.   +5 more
europepmc   +1 more source

Short-term outcomes of intravitreal faricimab on refractory neovascular age-related macular degeneration patients in China. [PDF]

Front Med (Lausanne)
Zhou F, Bai W, Zhao Y, Jiang Q, Wang C, Xu X, Yao J.   +6 more
europepmc   +1 more source

Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials. [PDF]

Ophthalmol Ther
Friedman SM, Xu Y, Sherman S, Kuznik A, Mojebi A, Keeping S, Chan K, Leng T, Patel NA.   +8 more
europepmc   +1 more source

Real-Life 1-Year Results and Predictors of Visual Outcome with Intravitreal Faricimab for Treatment of Exudative Neovascular Age-Related Macular Degeneration. [PDF]

Ophthalmol Ther
Beretta F, Scalabrin G, Balduzzi E, Puligheddu S, Bandello F, Sacconi R, Querques G.   +6 more
europepmc   +1 more source

Hard Exudates in Diabetic Macular Edema: Automated OCT Quantification and Longitudinal Response to Faricimab. [PDF]

Ophthalmol Sci
Scalabrin G, Perego F, Capobianco M, Veritti D, Borrelli E, Viggiano P, Boscia G, Bandello F, Lattanzio R, Cicinelli MV.   +9 more
europepmc   +1 more source

Comparison of Choroidal Morphological Changes Between Aflibercept 8 mg and Faricimab-svoa in Treatment-Naïve Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy. [PDF]

J Clin Med
Jeong S, Seong SH, Sagong M.
europepmc   +1 more source

Rapid resolution of submacular hemorrhage in neovascular age-related macular degeneration using pneumatic displacement and faricimab. [PDF]

BMC Ophthalmol
Ji PX, Herman JE, Sivachandran N.
europepmc   +1 more source

Changes in retinal venous diameter in proliferative diabetic retinopathy patients with diabetic macular edema following faricimab treatment: an observational study. [PDF]

Front Endocrinol (Lausanne)
Zhao H, Liu Y, Zhang L, Zhao X, Wang N, Tao Y, Wang H.   +6 more
europepmc   +1 more source

Artificial Intelligence-Assisted Analysis of Retinal Pigment Epithelium Tears in Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept (2 mg and 8 mg) and Faricimab: A Single-Centre Retrospective Case Series. [PDF]

J Clin Med
Eggarter V, Ruscitti L, Ascioti N, Bonanata M, Peyla A, Simona F, Menghini M, Grimaldi G.   +7 more
europepmc   +1 more source

Real-world outcomes after switching to faricimab in treatment-resistant diabetic macular edema: A 1-year observational study with choroidal thickness assessment. [PDF]

PLoS One
Tomemori R, Mori H, Tanaka M, Kiriishi T, Omi M, Hattori Y, Oba S, Ohnaka M, Imai H.   +8 more
europepmc   +1 more source